1. Home
  2. KLTOW vs CATY Comparison

KLTOW vs CATY Comparison

Compare KLTOW & CATY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTOW
  • CATY
  • Stock Information
  • Founded
  • KLTOW N/A
  • CATY 1962
  • Country
  • KLTOW United States
  • CATY United States
  • Employees
  • KLTOW 3
  • CATY N/A
  • Industry
  • KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
  • CATY Major Banks
  • Sector
  • KLTOW Health Care
  • CATY Finance
  • Exchange
  • KLTOW Nasdaq
  • CATY Nasdaq
  • Market Cap
  • KLTOW N/A
  • CATY 3.0B
  • IPO Year
  • KLTOW 2022
  • CATY N/A
  • Fundamental
  • Price
  • KLTOW $0.24
  • CATY $47.97
  • Analyst Decision
  • KLTOW
  • CATY Hold
  • Analyst Count
  • KLTOW 0
  • CATY 5
  • Target Price
  • KLTOW N/A
  • CATY $49.80
  • AVG Volume (30 Days)
  • KLTOW N/A
  • CATY 488.7K
  • Earning Date
  • KLTOW N/A
  • CATY 07-21-2025
  • Dividend Yield
  • KLTOW N/A
  • CATY 2.84%
  • EPS Growth
  • KLTOW N/A
  • CATY N/A
  • EPS
  • KLTOW N/A
  • CATY 3.95
  • Revenue
  • KLTOW N/A
  • CATY $691,279,000.00
  • Revenue This Year
  • KLTOW N/A
  • CATY $17.33
  • Revenue Next Year
  • KLTOW N/A
  • CATY $6.87
  • P/E Ratio
  • KLTOW N/A
  • CATY $12.14
  • Revenue Growth
  • KLTOW N/A
  • CATY N/A
  • 52 Week Low
  • KLTOW N/A
  • CATY $36.06
  • 52 Week High
  • KLTOW N/A
  • CATY $55.29
  • Technical
  • Relative Strength Index (RSI)
  • KLTOW N/A
  • CATY 72.77
  • Support Level
  • KLTOW N/A
  • CATY $45.30
  • Resistance Level
  • KLTOW N/A
  • CATY $45.45
  • Average True Range (ATR)
  • KLTOW 0.00
  • CATY 1.04
  • MACD
  • KLTOW 0.00
  • CATY 0.40
  • Stochastic Oscillator
  • KLTOW 0.00
  • CATY 91.76

About KLTOW Klotho Neurosciences Inc. Warrant

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About CATY Cathay General Bancorp

Cathay General Bancorp is a regional bank predominantly serving the Chinese-American community. The company's policy is to reach out and actively offer services to low-to-moderate income groups in the delineated branch service areas. It predominantly provides services such as checking and deposit, lines of credits, commercial and commercial real estate loans, merchant services and payment processing, treasury management services, international banking and financing services, and other customary banking services to individuals, professionals, and small to medium-sized businesses. Through its Wealth Management unit, the company also offers investment products and services, such as stocks, bonds, mutual funds, insurance, annuities and advisory services.

Share on Social Networks: